USANA (USNA) files Form 144 for 5,169-share sale via Morgan Stanley
Rhea-AI Filing Summary
USANA Health Sciences (USNA) filer submitted a Form 144 proposing the sale of 5,169 common shares through Morgan Stanley Smith Barney on the NYSE. The shares have an aggregate market value of $165,408 and the issuer reports 18,271,836 shares outstanding, making the sale a small fraction of total shares. The shares were acquired as restricted stock in early February 2025 (944 on 02/07/2025, 2,805 on 02/08/2025 and 1,420 on 02/06/2025) and the approximate sale date is listed as 08/28/2025. The filing includes the standard representation that the seller is not aware of undisclosed material adverse information.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine insider notification of a planned sale; size appears immaterial relative to shares outstanding.
The Form 144 documents a proposed disposition of 5,169 USNA common shares via Morgan Stanley Smith Barney with an aggregated value of $165,408 and an approximate sale date of August 28, 2025. The underlying shares were issued as restricted stock in early February 2025. Compared with the reported 18,271,836 shares outstanding, this represents a very small percentage of the float, indicating the filing is procedural and unlikely to have material market impact. The disclosure includes the customary attestation regarding material nonpublic information, and no other transactions in the prior three months are reported.
TL;DR: Proper Rule 144 notice for planned sale; compliance appears complete but provides limited substantive detail.
The submission lists broker details, exact share counts, acquisition dates and types (restricted stock), and attests to absence of undisclosed material information. These elements satisfy Form 144 requirements for notifying the market of a proposed sale under Rule 144. There is no indication of an adopted trading plan or 10b5-1 scheduling in the remarks, and no prior sales reported in the past three months. From a governance perspective, documentation appears routine and compliant.